Omaveloxolone Driven NRF2 Activation as a Novel Therapeutic Strategy for Pulmonary Hypertension.

已完结 10 由 LILLIAN 发布于 2026/8/26 18:59:39

DOI:10.1161/HYPERTENSIONAHA.126.26711
作者：Chuangjia Huang,?June Bai,?Ang Luo,?Lei Yang,?Xingting Wang,?Linlin Dang,?Changlei Bao,?Jinsheng Zhu,?Zixuan Chen,?Bitao Wu,?Jintao Long,?Jieyi Feng,?Zinan Luo,?Yingying Xiao,?Hanliang Sun,?Shuxin Lia
文献类型：期刊论文
补充材料：只需要正文

Wolters Kluwer Ovid

Abstract：Background: Pulmonary arterial hypertension is a progressive and life-threatening disorder characterized by elevated pulmonary arterial pressure, right ventricular hypertrophy, and eventual

应助信息

1天前

Book学术机器人

c6dd3bb89b6e11f1b2d034735aa3bc31.pdf 已采纳

1天前

Book学术机器人

2026/8/26 18:59:39 Book学术AI机器人已找到文献并上传

2026/8/26 18:59:39 Book学术AI机器人收到请求，开始寻找文献

2026/8/26 18:59:39 已向机器人发送请求

1天前

LILLIAN 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库miR487a-3p and miR6855-3p Facilitate Macrophage Proinflammatory Polarization and Lipid Accumulation in Atherosclerosis.